Aileron Therapeutics Inc. (ALRN) Fundamentals

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects.
SHARE INFORMATION
Market Cap$ 20,662,368
Shares Outstanding90,823,597
Float71,148,184
Percent Float78.34%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.28
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions73
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months333,019
Institutional Holdings Percent42.7%
Institutional Sold Previous 3 Months1,722,035
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months327,000
Insider Holdings Percent1.4
Insider Sold Previous 3 Months-
Insider Shares Owned1,247,880
TRADING INFO
52 Week High$ 1.12
52 Week Low$ 0.13
52 Week High Change$ -79.32
21 Day Moving Average$ 0.2101
21 Day Extended Moving Average$ 0.220983
50 Day Moving Average$ 0.2035
50 Day Extended Moving Average$ 0.232626
200 Day Moving Average$ 0.394246
200 Day Extended Moving Average$ 0.431296
10 Day Average Volume2,862,291
20 Day Average Volume1,585,420
30 Day Average Volume1,299,519
50 Day Average Volume1,386,918
Alpha-0.038517
Beta2.2670
Standard Deviation0.366654
R20.097331
7 Day Price Change$ -0.0525
7 Day Percent Change-18.75%
21 Day Price Change$ 0.0574
21 Day Percent Change33.74%
30 Day Price Change$ 0.0275
30 Day Percent Change13.75%
Month to Date Price Change$ 0.0424
Month to Date Percent Change22.91%
Quarter to Date Price Change$ -0.0325
Quarter to Date Percent Change-12.5%
180 Day Price Change$ -0.2125
180 Day Percent Change-48.3%
200 Day Price Change$ -0.1984
200 Day Percent Change-46.58%
Year to Date Price Change$ -0.3354
Year to Date Percent Change-59.58%

Aileron Therapeutics Inc. (ALRN) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.70
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio6.50
Leverage Ratio1.10
Quick Ratio6.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.70
Enterprise Value$ -11,256,338
Price to Sales0.00
Price to Free Cash-0.80
PE High Last 5 Years-0.90
Price To Book0.70
Price To Cash Flow0.00
PE Low Last 5 Years-4.60
Price to Tangible Book0.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-68.57
Return on Equity-76.49
Return on Capital-70.34

Aileron Therapeutics Inc. (ALRN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOManuel C. Alves Aivado
Emplyoees9
Last AuditUQ
CIK0001420565
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address285 Summer Street
Unit 101
Boston, MA 2210
Websitehttps://www.aileronrx.com
Facsimile+1 617 995-2410
Telephone+1 617 995-0900
Emailddougherty@aileronrx.com


Your Recent History
NASDAQ
ALRN
Aileron Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.